candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract은 임신 중 안전한가요?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR reproductive contraindications were identified for microbial/yeast ferment extracts of the listed species; peer‑reviewed literature does not indicate teratogenicity or reproductive toxicity for topical use of such ferments. Cosmetic safety databases (CosIng/EWG) commonly list these as ferment extracts without reproduction flags, consistent with CIR precedent that cosmetic ferments are 'safe as used' when appropriately processed.

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract은 모유 수유 중 안전한가요?

No evidence from regulatory sources or peer‑reviewed studies suggests systemic reproductive toxicity or secretion into breast milk from topical application of these microbial ferment extracts; no harmonised classifications or SCCS/CIR warnings were found.

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract은 아기 피부에 안전한가요?

Hazard and mechanism: no infant‑specific reproductive or developmental effects located. Exposure: dermal absorption from topical ferments is expected to be negligible in adults, but per guidance infant exposure scoring is increased by +1 due to higher surface‑area‑to‑weight and immature barrier, so exposure is assigned 1 for 0–3 yr skin even though systemic absorption is still expected to be low. Note: potential for topical sensitization or infection in severely immunocompromised infants is a general consideration but not a reproductive/developmental finding.

VeriMom은 candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.